NetworkNewsBreaks – ABcann Global Corp. (TSX.V:
Post# of 111
(Total Views: 305)
Posted On: 01/18/2018 7:41:50 PM
NetworkNewsBreaks – ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) Subsidiary Receives Import License from Australia
ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF), through wholly-owned subsidiary ABcann Australia Pty Ltd., this morning announced that it has received an import license from the Federal Office of Drug Control in Australia. Following receipt of necessary approvals, including approval from the TSX Venture Exchange, ABcann intends to supply medicinal cannabis to the Australian market via the Australian Department of Health’s Therapeutic Goods Administration (“TGA”) Special Access Scheme. “This import license is a key milestone towards generating revenue through ABcann’s network of physicians, pharmacists and patients, and advancing the use of medical cannabis,” Barry Fishman, chief executive officer of ABcann, stated in the news release. “We view Australia as an important emerging market for medical cannabis and I look forward to meeting with our strategic partners and stakeholders in Australia later this month to further discuss opportunities there.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF), through wholly-owned subsidiary ABcann Australia Pty Ltd., this morning announced that it has received an import license from the Federal Office of Drug Control in Australia. Following receipt of necessary approvals, including approval from the TSX Venture Exchange, ABcann intends to supply medicinal cannabis to the Australian market via the Australian Department of Health’s Therapeutic Goods Administration (“TGA”) Special Access Scheme. “This import license is a key milestone towards generating revenue through ABcann’s network of physicians, pharmacists and patients, and advancing the use of medical cannabis,” Barry Fishman, chief executive officer of ABcann, stated in the news release. “We view Australia as an important emerging market for medical cannabis and I look forward to meeting with our strategic partners and stakeholders in Australia later this month to further discuss opportunities there.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)